Global $490.11 Mn Flow Cytometry Market Growth, Trends, and Forecasts 2019-2024 – ResearchAndMarkets.com
March 20, 2019DUBLIN–(BUSINESS WIRE)–The “Flow
Cytometry Market – Growth, Trends, and Forecast (2019 – 2024)”
report has been added to ResearchAndMarkets.com’s
offering.
The global flow cytometry market was valued at USD 303.51 million in
2018 and is estimated to reach USD 490.11 million in 2024, while
witnessing a CAGR of 8.3% during the forecast period, 2019-2024.
The key factors propelling the market include the rise in the use of
flow cytometry in stem cell research, the emergence and commercial
application of new technologies in the field of flow cytometry, and rise
in the applications of flow cytometry in clinical research.
There is a significance of flow cytometry in clinical research that is
fueling the demand for flow cytometry techniques in R&D departments of
the healthcare sector. The increasing incidences of HIV and cancer
statistics show a significant unmet opportunity in cancer and AIDS
diagnostics. There is a large void in diagnostics accessibility,
particularly in the developing regions. Consequently, the increasing
incidences of HIV AIDS and cancer can be considered a significant growth
opportunity for the flow cytometry market.
Scope of the Report
Flow cytometry is a laser or an impedance-based technology, which is
used in cell counting, detecting biomarker, cell sorting, and protein
engineering, by suspending the cell in a stream of fluid and then
passing them through a detection apparatus. It is the ideal tool to
identify, characterize, and isolate stem and progenitor cells, for
research and potential clinical use.
Key Market Trends
Stem Cell Therapy is Expected to Hold the Largest Market Share, by
Application
The stem cell therapy segment is believed to have the largest market
size and is expected to witness a CAGR of 8.4% during the forecast
period.
The key reasons for the large market share include the extensive use of
flow cytometry for effective diagnosis and early detection of numerous
diseases that have helped the market to gain immense shares. There has
been a growing market penetration in stem cell research, adoption of
recombinant DNA technology for antibody production, and the evolution of
tandem flow cytometry technologies that are expected to offer growth
opportunities for the players operating in the flow cytometry market
during the forecast period.
Though flow cytometry has also found many applications in several stages
of drug discovery, its routine widespread use for high throughput drug
screening has been limited. This is unlike analogous technology,
automated high content imaging (HCI), which, in terms of drug screening,
is an established technology that is common in screening laboratories.
North America Dominates the Market and is Expected to Continue its Lead
over the Forecast Period
North America holds a major share of the flow cytometry market and is
projected to continue over the next few years. An increasing prevalence
of diseases and the rising contribution from the US market are expected
to help the market grow. In addition, there has also been a rise in the
expansion of novel products that are anticipated to offer new growth
opportunities in the coming years.
Competitive Landscape
The flow cytometry market is considered highly consolidated due to the
presence of very few players in the market. These players are holding a
huge share of the market and are likely to remain in a similar
competitive environment for the next few years. The rising importance of
product development and the rise in R&D activities are projected to
encourage the growth of the flow cytometry market.
Key Topics Covered:
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Use of Flow Cytometry in Stem Cell Research
4.2.2 Emergence and Commercial Applications of New Technologies in the
Field of Flow Cytometry
4.2.3 Increasing Applications of Flow Cytometry in Clinical Research
4.3 Market Restraints
4.3.1 Lack of Awareness about the Potential Benefits of Flow Cytometry
Techniques
4.3.2 Expensive Equipment
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Instrument
5.1.2 Fluorophore
5.1.3 Kit and Reagent
5.1.4 Software
5.1.5 Other Product Types
5.2 Technology
5.2.1 Cell-based Flow Cytometry
5.2.2 Bead-based Flow Cytometry
5.3 Application
5.3.1 Oncology
5.3.2 Drug Discovery
5.3.3 Disease Diagnosis
5.3.4 Stem Cell Therapy
5.3.5 Organ Transplantation
5.3.6 Hematology
5.3.7 Other Applications
5.4 By End User
5.4.1 Hospitals and Clinics
5.4.2 Academia and Research Institutes
5.4.3 Pharmaceutical and Biotechnology Companies
5.4.4 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 US
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 UK
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Beckman Coulter
6.1.3 EMD Millipore (Merck KGaA)
6.1.4 Bio-Rad Laboratories
6.1.5 Luminex Corporation
6.1.6 Life Technologies
6.1.7 Miltenyi Biotech
6.1.8 Sysmex Partec GmbH
6.1.9 Agilent Technologies
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/research/p27bfp/global_490_11_mn?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology
